Your session is about to expire
← Back to Search
This trial will help researchers understand why people with spinal cord injuries often eat more calories than they need, in order to stay alive and function.
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a Location
Who is running the clinical trial?
- People with tetraplegia who can feed themselves.You are currently trying to lose weight through a diet or weight loss program.You have been diagnosed with diabetes in the past.You have had thyroid disease in the past.You have a history of stomach or intestine problems that you have reported yourself.You are using a prosthetic device for your peripheral nervous system.You have trouble swallowing.You have reported that you are allergic to or do not like the meals being tested.You are taking certain medications for stomach or mental health issues.People who are not grown-ups (babies, kids, teenagers)Adults who are 18 years or older and have tetraplegia (C5-C8) or paraplegia (T1-L2) spinal cord injury.You have had a spinal cord injury for more than 12 months.You have specific levels of spinal cord injury according to the American Spinal Injury Association Impairment Scale.People who are unable to feed themselves due to paralysis in all four limbs.You have a bowel care routine that you follow every other day.We are looking for adults 18 years or older who do not have a spinal cord injury.You must be able to follow a specific bowel care program every other day.Adults aged 18 or older with spinal cord injuries affecting the neck (C5-C8) or lower back (T1-L2).You have a specific level of spinal cord injury categorized as A, B, or C.You have had a spinal cord injury for at least 12 months.
- Group 1: Spinal Cord Injury Group
- Group 2: Control Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the intent of this clinical exploration?
"The main goal of this clinical trial, lasting up to a week, is to estimate gastric emptying time. Secondary measurements include changes in postprandial ghrelin (as determined by serum blood samples), total body fat percentage (measured through Dual x-ray absorptiometry DXA) and fluctuations in postprandial peptide tyrosine tyrosine PYY (also evaluated via serum blood samples)."
Are additional participants being sought for the experiment?
"This research, which was posted at the start of 2021 and last updated in November 2022, is no longer recruiting patients. Nonetheless, there are 352 other trials that currently need participants."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Most responsive sites:
- University of Miami: < 24 hours
Average response time
- < 1 Day
Typically responds via
Share this study with friends